Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more
JAMA Editors' Summary · American Medical Association
May 9, 20177m 44s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
May 09, 2017 edition of the weekly JAMA Editors' Summary